Polypharmacy in older adults with HIV infection: Effects on the brain.
作者信息
Smith Lauren, Letendre Scott, Erlandson Kristine M, Ma Qing, Ellis Ronald J, Farhadian Shelli F
机构信息
Section of Infectious Diseases, Yale University School of Medicine, New Haven, Connecticut, USA.
Department of Infectious Diseases, University of California San Diego School of Medicine, San Diego, California, USA.
出版信息
J Am Geriatr Soc. 2022 Mar;70(3):924-927. doi: 10.1111/jgs.17569. Epub 2021 Dec 1.
Abstract
摘要
相似文献
1
Polypharmacy in older adults with HIV infection: Effects on the brain.老年HIV感染者的多重用药：对大脑的影响。
J Am Geriatr Soc. 2022 Mar;70(3):924-927. doi: 10.1111/jgs.17569. Epub 2021 Dec 1.
2
Polypharmacy in the HIV-infected older adult population.老年 HIV 感染者的多种药物治疗。
Clin Interv Aging. 2013;8:749-63. doi: 10.2147/CIA.S37738. Epub 2013 Jun 21.
3
[The HIV population is aging].感染艾滋病毒的人群正在老龄化。
Ugeskr Laeger. 2013 Nov 18;175(47):2870-3.
4
HIV in older adults.老年人中的艾滋病毒。
Geriatrics. 2008 Dec;63(12):6-12.
5
The increasing burden and complexity of multi-morbidity and polypharmacy in geriatric HIV patients: a cross sectional study of people aged 65 - 74 years and more than 75 years.老年 HIV 患者多病共存和多种药物治疗负担日益加重且日趋复杂：65-74 岁及 75 岁以上人群的横断面研究。
BMC Geriatr. 2018 Apr 20;18(1):99. doi: 10.1186/s12877-018-0789-0.
6
Prevalence and trends of polypharmacy among HIV-positive and -negative men in the Multicenter AIDS Cohort Study from 2004 to 2016.2004 年至 2016 年多中心艾滋病队列研究中 HIV 阳性和阴性男性患者的多种药物治疗流行率和趋势。
PLoS One. 2018 Sep 11;13(9):e0203890. doi: 10.1371/journal.pone.0203890. eCollection 2018.
7
Addressing Polypharmacy in Older Adults Living With HIV.解决老年HIV感染者的多重用药问题。
J Assoc Nurses AIDS Care. 2019 Jan-Feb;30(1):73-79. doi: 10.1097/JNC.0000000000000028.
8
Polypharmacy in older adults with human immunodeficiency virus infection compared with the general population.与普通人群相比，老年人类免疫缺陷病毒感染者的多重用药情况。
Clin Interv Aging. 2016 Aug 26;11:1149-57. doi: 10.2147/CIA.S108072. eCollection 2016.
9
Short Communication: Getting Older with HIV: Increasing Frequency of Comorbidities and Polypharmacy in Brazilian HIV Patients.短讯：与艾滋病毒共同变老：巴西艾滋病毒患者中合并症和多重用药的频率增加。
AIDS Res Hum Retroviruses. 2019 Nov/Dec;35(11-12):1103-1105. doi: 10.1089/AID.2019.0069. Epub 2019 Sep 30.
10
Comorbidities in Older Persons with Controlled HIV Infection: Correlations with Frailty Index Subtypes.老年人中合并症与控制的 HIV 感染：与虚弱指数亚型的相关性。
AIDS Patient Care STDS. 2020 Jul;34(7):284-294. doi: 10.1089/apc.2020.0051.
引用本文的文献
1
Executive Functioning Training for Reducing Cognitive Intra-Individual Variability in People Living with HIV: A Pilot Randomized, Controlled Trial Protocol.执行功能训练以降低艾滋病毒感染者的认知个体内变异性：一项试点随机对照试验方案
Nursing (Auckl). 2025;15:17-28. doi: 10.2147/nrr.s492990. Epub 2025 Feb 17.
2
Use of Nonrecommended Antivirals Among Medicare Beneficiaries With HIV.医疗保险受益人中艾滋病毒感染者使用非推荐抗病毒药物的情况。
JAMA Netw Open. 2025 May 1;8(5):e258296. doi: 10.1001/jamanetworkopen.2025.8296.
3
Predicting Neurobehavioral Outcomes in People with HIV.预测HIV感染者的神经行为学转归
Res Sq. 2025 Mar 27:rs.3.rs-5618870. doi: 10.21203/rs.3.rs-5618870/v1.
本文引用的文献
1
Effects of anticholinergic medication use on brain integrity in persons living with HIV and persons without HIV.抗胆碱能药物使用对 HIV 感染者和非 HIV 感染者大脑完整性的影响。
AIDS. 2021 Mar 1;35(3):381-391. doi: 10.1097/QAD.0000000000002768.
2
A patient-centred approach to deprescribing antiretroviral therapy in people living with HIV.以患者为中心的抗逆转录病毒疗法逐渐停药方案用于 HIV 感染者。
J Antimicrob Chemother. 2020 Dec 1;75(12):3425-3432. doi: 10.1093/jac/dkaa329.
3
Deprescribing of non-antiretroviral therapy in HIV-infected patients.对感染艾滋病毒患者停用非抗逆转录病毒疗法
Eur J Clin Pharmacol. 2020 Mar;76(3):305-318. doi: 10.1007/s00228-019-02785-z. Epub 2019 Dec 21.
4
Polypharmacy in HIV: recent insights and future directions.HIV 患者的多种药物治疗：最新研究进展与未来方向。
Curr Opin HIV AIDS. 2020 Mar;15(2):126-133. doi: 10.1097/COH.0000000000000608.
5
Incomplete ART adherence is associated with higher inflammation in individuals who achieved virologic suppression in the START study.在 START 研究中达到病毒学抑制的个体中，不完全 ART 依从性与更高的炎症相关。
J Int AIDS Soc. 2019 Jun;22(6):e25297. doi: 10.1002/jia2.25297.
6
Non-HIV Comorbid Conditions and Polypharmacy Among People Living with HIV Age 65 or Older Compared with HIV-Negative Individuals Age 65 or Older in the United States: A Retrospective Claims-Based Analysis.美国 65 岁及以上 HIV 感染者与 HIV 阴性 65 岁及以上个体相比的非 HIV 合并症和多药治疗：一项基于回顾性索赔的分析。
AIDS Patient Care STDS. 2019 Mar;33(3):93-103. doi: 10.1089/apc.2018.0190.
7
Polypharmacy and drug-drug interactions in older and younger people living with HIV: the POPPY study.老年和年轻HIV感染者的多重用药及药物相互作用：罂粟花研究
Antivir Ther. 2019;24(3):193-201. doi: 10.3851/IMP3293.
8
Prevalence and trends of polypharmacy among HIV-positive and -negative men in the Multicenter AIDS Cohort Study from 2004 to 2016.2004 年至 2016 年多中心艾滋病队列研究中 HIV 阳性和阴性男性患者的多种药物治疗流行率和趋势。
PLoS One. 2018 Sep 11;13(9):e0203890. doi: 10.1371/journal.pone.0203890. eCollection 2018.
9
Polypharmacy among HIV positive older adults on anti-retroviral therapy attending an urban clinic in Uganda.抗逆转录病毒疗法治疗的乌干达城市诊所中 HIV 阳性老年患者的多药治疗情况。
BMC Geriatr. 2018 May 29;18(1):125. doi: 10.1186/s12877-018-0817-0.
10
Cognitive Burden of Common Non-antiretroviral Medications in HIV-Infected Women.HIV 感染女性常见非抗逆转录病毒药物的认知负担。
J Acquir Immune Defic Syndr. 2018 Sep 1;79(1):83-91. doi: 10.1097/QAI.0000000000001755.
Zotero 插件